Trial Profile
Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function and Other Circulating Biomarkers in Humans
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Aug 2022
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel; Prasugrel
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms Hi Tech
- 25 Jun 2021 According to a Labcorp company website, Covance has changed its name to LabCorp Drug Development.
- 10 Feb 2017 Status changed from active, no longer recruiting to completed.
- 04 Nov 2016 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.